PROMONTORY THERAPEUTICS
Promontory Therapeutics Inc. is a clinical stage pharmaceutical company developing small molecule immunotherapies. The company's lead candidate, PT-112, is a novel chemical entity under clinical development that exhibits a unique combination of properties, including immunogenic cell death as well as osteotropism that confers advantages in dealing with cancers that originate in or metastasize to the bone. Clinical data generated to date across three Phase 1 studies have demonstrated single-agent ... anti-cancer activity and an attractive tolerability pro๏ฌle, and three Phase 2 studies of PT-112 are underway. The company also sponsors the ongoing clinical study of PT-112 in combination with the PD-L1 inhibitor avelumab under a collaboration agreement with P๏ฌzer and Merck KGaA, Darmstadt, Germany (operating as EMD Serono in the US and Canada), and has an active collaborative research and development agreement (CRADA) with the NCI to conduct a Phase 2 trial utilizing PT-112 in thymic epithelial tumors.
PROMONTORY THERAPEUTICS
Industry:
Biotechnology Life Science Oncology Pharmaceutical
Founded:
2010-11-15
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.promontorytx.com
Total Employee:
11+
Status:
Active
Contact:
+1 646 380-2441
Email Addresses:
[email protected]
Total Funding:
72.01 M USD
Technology used in webpage:
SPF Amazon Organization Schema Google Apps For Business GoDaddy DNS AWS Global Accelerator
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Vittoria Biotherapeutics
Vittoria Biotherapeutics is a gene-edited cell therapeutics company.
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-11-28 | Promontory Therapeutics Appoints Stan Musial as Chief Financial Officer |
| 2022-09-13 | Promontory Therapeutics Appoints Two Experienced Executives to Its Core Management Team |
Official Site Inspections
http://www.promontorytx.com Semrush global rank: 15.84 M Semrush visits lastest month: 1
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Promontory Therapeutics"
Leadership | Promontory Therapeutics | Advancing small molecule ...
Von Hoff is the past President of the American Association for Cancer Research (the worldโs largest cancer research organization), a Fellow of the American College of Physicians, and a โฆSee details»
Promontory Therapeutics - Crunchbase Company Profile & Funding
Promontory Therapeutics Inc. is a clinical stage pharmaceutical company developing small molecule immunotherapies. The company's lead candidate, PT-112, is a novel chemical entity โฆSee details»
Phosplatin Therapeutics Adopts New Corporate Name as โฆ
May 5, 2022 To learn more about Promontory Therapeuticsโ mission, as well as PT-112 visit promontorytx.com. About Promontory Therapeutics. Promontory Therapeutics Inc. is a โฆSee details»
Promontory Therapeutics - LinkedIn
Promontory Therapeutics | 2,247 followers on LinkedIn. Phase 2 stage biotech company developing novel small-molecule anti-cancer immunotherapies. | Promontory Therapeutics is a private, clinical ...See details»
Promontory Therapeutics Appoints Two Experienced Executives to โฆ
Sep 13, 2022 Helene Shea as Vice President of Chemistry, Manufacturing and Controls, and Kate Hogg Call as Vice President of Clinical Operations. NEW YORK, Sept. 13, 2022 โฆSee details»
Promontory Therapeutics - BIO CEO & Investor Conference | BIO
Feb 7, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ...See details»
Promontory Therapeutics Completes Enrollment of Phase 2 Trial of โฆ
Mar 8, 2024 Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing immunogenic small molecule approaches in oncology, has completed enrollment of its Phase โฆSee details»
Promontory Therapeutics | VentureRadar
Website: https://promontorytx.com/ We are developing novel small molecules that engage an anti-cancer immune response. Our lead candidate, PT-112, is the first ever ...See details»
Promontory Therapeutics, Inc. in New York, NY - (646) 380-2441
Promontory Therapeutics, Inc. is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»
Promontory Therapeutics - Company Profile - Tracxn
Nov 13, 2024 Promontory Therapeutics ranks 588th among 2362 active competitors. 847 of its competitors are funded while 544 have exited. Overall, Promontory Therapeutics and its โฆSee details»
Contact Us | Promontory Therapeutics | Advancing small molecule ...
Reach out to us. [email protected] (646) 380-2441. 1350 Avenue of the Americas 23rd Floor New York, NY 10019See details»
Promontory Therapeutics Overview - Salary.com
Discover essential details about Promontory Therapeutics, including address, contact, and journey of our company's evolution.See details»
Promontory Therapeutics (@PromontoryTx) / Twitter
Apr 7, 2022 Promontory is a private, clinical stage pharma company developing novel small-molecule anti-cancer agents that promote adaptive immune responses.See details»
Promontory Therapeutics Selected as the First International โฆ
Sep 29, 2023 Paris-Saclay Cancer Cluster was recently formed to become the leading European hub for research and innovation in oncology Promontory builds upon its recent expansion to โฆSee details»
Promontory Therapeutics Email Format | promontorytx.com Emails
The most common Promontory Therapeutics email format. is [first_initial][last] (ex. [email protected]), which is being used by 100.0% of Promontory Therapeutics work โฆSee details»
Promontory Therapeutics | VentureRadar
Similar Companies: Phosplatin Therapeutics USA Privately Held Promontory Therapeutics is at the forefront of oncology, addressing unmet needs and solving unresolved problems in cancer โฆSee details»
Promontory - Overview, News & Similar companies | ZoomInfo.com
Who is Promontory. Promontory is an award-winning 6,400-acre recreational second home and private mountain community in Park City, Utah. Promontory's expansive mounta in setting โฆSee details»
Careers | Promontory Therapeutics | Advancing small molecule โฆ
[email protected] . Promontory Therapeutics. 1350 Avenue of the Americas, 23rd Floor New York, NY 10019 ...See details»
Promontory Therapeutics Awarded โCancer Immunology Solution โฆ
NEW YORK (PRWEB) - November 03, 2022 - Promontory Therapeutics Inc., a clinical stage biotech company advancing small molecule immunotherapies in oncology, today announced it โฆSee details»